Cervical cancer is a global public health problem, with a particularly high burden in many low-income and middle-income countries (LMICs). The proven effectiveness of intervention measures, such as vaccination against the most oncogenic human papilloma virus (HPV) types(1) and screening , makes cervical cancer a largely preventable disease. (2) Among women globally, Cervical cancer is the fourth most common neoplasm and the fourth leading cause of cancer death (3) The literature demonstrated that, unlike global trends, cervical cancer incidence in Saudi Arabia is increasing. In addition to that, a high proportion of it is discovered in advanced stages. This state of late discovery was attributed to the absence of efficient preventive and screening programs.(4) The incidence of cervical cancer in 2020 was 358 (the crude incidence per 100,000 women was 2.4 and the mortality incidence ratio was 0.5) (5-6) By 2030, the yearly incidence of cervical cancer is expected to jump to 700,000, and the number of deaths is predicted to increase to 400,000 if no further intervention is done (7)